Terms: = Leukemia AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Clinical Outcome
11 results:
1. Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Tanaka N; Mori S; Kiyotani K; Ota Y; Gotoh O; Kusumoto S; Nakano N; Suehiro Y; Ito A; Choi I; Ohtsuka E; Hidaka M; Nosaka K; Yoshimitsu M; Imaizumi Y; Iida S; Utsunomiya A; Noda T; Nishikawa H; Ueda R; Ishida T
Haematologica; 2022 Oct; 107(10):2418-2431. PubMed ID: 35417939
[TBL] [Abstract] [Full Text] [Related]
2. [Clonal heterogeneity and its prognostic significance in acute lymphoblastic leukemia].
Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
Zhonghua Nei Ke Za Zhi; 2020 Aug; 59(8):629-633. PubMed ID: 34865381
[No Abstract] [Full Text] [Related]
3. The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis.
Albano F; Chiurazzi F; Mimmi S; Vecchio E; Pastore A; Cimmino C; Frieri C; Iaccino E; Pisano A; Golino G; Fiume G; Mallardo M; Scala G; Quinto I
Cell Death Dis; 2018 Jan; 9(1):13. PubMed ID: 29317636
[TBL] [Abstract] [Full Text] [Related]
4. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; MartÃn-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
[TBL] [Abstract] [Full Text] [Related]
5. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.
Shahjahani M; Mohammadiasl J; Noroozi F; Seghatoleslami M; Shahrabi S; Saba F; Saki N
Cell Oncol (Dordr); 2015 Apr; 38(2):93-109. PubMed ID: 25563586
[TBL] [Abstract] [Full Text] [Related]
6. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.
Lionetti M; Musto P; Di Martino MT; Fabris S; Agnelli L; Todoerti K; Tuana G; Mosca L; Gallo Cantafio ME; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omede' P; Morabito F; Tassone P; Boccadoro M; Palumbo A; Neri A
Clin Cancer Res; 2013 Jun; 19(12):3130-42. PubMed ID: 23613318
[TBL] [Abstract] [Full Text] [Related]
7. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.
Balgobind BV; Hollink IH; Arentsen-Peters ST; Zimmermann M; Harbott J; Beverloo HB; von Bergh AR; Cloos J; Kaspers GJ; de Haas V; Zemanova Z; Stary J; Cayuela JM; Baruchel A; Creutzig U; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
Haematologica; 2011 Oct; 96(10):1478-87. PubMed ID: 21791472
[TBL] [Abstract] [Full Text] [Related]
8. Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.
Galligan L; Catherwood MA; Matthews C; Morris TC; Alexander HD
Leuk Lymphoma; 2008 Apr; 49(4):763-8. PubMed ID: 18398745
[TBL] [Abstract] [Full Text] [Related]
9. Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemia.
Hess CJ; Berkhof J; Denkers F; Ossenkoppele GJ; Schouten JP; Oudejans JJ; Waisfisz Q; Schuurhuis GJ
J Clin Oncol; 2007 Apr; 25(10):1209-15. PubMed ID: 17401010
[TBL] [Abstract] [Full Text] [Related]
10. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract] [Full Text] [Related]
11. Minimal residual disease in early phase of chemotherapy reflects poor outcome in children with acute lymphoblastic leukemia--a retrospective study by the Children's Cancer and leukemia Study Group in Japan.
Okamoto T; Yokota S; Katano N; Seriu T; Nakao M; Taniwaki M; Watanabe A; Asami K; Kikuta A; Koizumi S; Kawakami T; Ohta S; Miyake M; Watanabe T; Iwai A; Kamitamari A; Ijichi O; Hyakuna N; Mimaya J; Fujimoto T; Tsurusawa M
Leuk Lymphoma; 2002 May; 43(5):1001-6. PubMed ID: 12148878
[TBL] [Abstract] [Full Text] [Related]
